JPM Upgrade to Market Outperform on 4/7/16.......
I bought some 5.20s.......and plan to add if this dips again. Chart looks ripe.
Keep in mind this was a $16.00 plus stock a year ago. Basically one failed trial brought it down. Should be back there in no time especially if bought
GBSN is the biggest Scam dilution machine going. It will be back down to the penny range in no time. DON"T BUY THIS SCAM
watch closely this stock, can go up big time any time. One of the analyst target this $87.50 after the 2 FDA clearance.
Come see this. ULTIMATE STOCK ALERTS is one of the best services I have found online. If your
interested in trading small cap stocks that fly google the name and sign up.
I have no position in RPTP. I’m jumped in numerous time on explores sale news in the past. Example PTCT - only to get hurt big time the next day. I hope RPTP sale news is legit this time for you all. I’m not jumping into this explores sales B.S. Good Luck to RPTP holders.
4 Mins AgoReuters
COMMENTSStart the Discussion
(Adds share reaction, more details)
April 6 (Reuters) - Raptor Pharmaceutical Corp, a U.S. company that develops drugs to treat orphan diseases, is reaching out to investment banks for a financial adviser to explore a sale of itself, according to people familiar with the matter.
The pharmaceutical industry is taking a greater interest in so-called orphan drugs because their strong patent protection helps ensure reliable pricing power for drug makers.
At the same time, volatile markets are making it difficult for small life sciences companies with expansive development pipelines such as Raptor's to raise cash for research. This in turn makes these small companies more inclined to sell themselves to a well capitalized acquirer.
Raptor's move is exploratory and may not lead to a sale, the people said this week, asking not to be identified because the deliberations are confidential.